Science & Medicine
A drug used for maintenance treatment of bipolar disorder lacks evidence, scientists contend
May 3, 2011
Business
Bristol-Myers Squibb Co. moved closer to Food and Drug Administration approval of the Abilify schizophrenia drug, which may be the company’s next big product.
Sept. 4, 2002
U.S. regulators have approved the first drug with a sensor that can track whether patients have taken their medicine.
Nov. 14, 2017
About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify “might be right for them.”
April 13, 2009
Atypical antipsychotics: too hard a sell?
Use of atypical antipsychotics for lesser disorders is gaining ground, despite safety concerns
Bristol-Myers Squibb Co. and a former subsidiary have agreed to pay more than $515 million to settle federal and state investigations into their drug marketing practices.
Sept. 29, 2007
Archives
A TERRIBLE rhythmic noise from the living room, like a dull saw in hard wood, woke me. 4:11 a.m.
Nov. 5, 2006
Booster Shots
This article was originally on a blog post platform and may be missing photos, graphics or links.
April 1, 2010
U.S. regulators have requested that six of the most widely used anti-psychotic drugs carry a warning that they can increase the risk of elevated blood sugar and diabetes, Eli Lilly & Co. said.
Sept. 18, 2003